SpringWorks Therapeutics is committed to building strong partnerships to develop new medicines for the patients and families that are counting on us. By working together, we can ignite the power of promising science to unleash new possibilities for patients.
Expanding our pipeline through preclinical and clinical collaborations is a key component of our business model. SpringWorks has created a channel for evaluating additional assets to license from Pfizer and is also actively pursuing new licensing and partnership opportunities with other innovators. We are working to grow our portfolio and to leverage our best-in-class clinical development capabilities to help advance promising science as efficiently as possible.
If you are interested in partnering with SpringWorks, please contact us at email@example.com.
We focus on developing true partnerships, with patients at the center of our ambitions and efforts. Our belief is that by teaming with innovators and advocates across patient groups, academic institutions, and industry, we can collectively create new solutions for the patients who are counting on us.